13D/13G Filings - Aptevo Therapeutics Inc. (APVO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-11-27
2:30 pm
Purchase
2020-11-17 13G Aptevo Therapeutics Inc.
APVO
HIRSCHMAN ORIN 75
2.950%
75increase
(New Position)
Filing
History
2020-11-18
5:03 pm
Unchanged
2020-11-03 13D Aptevo Therapeutics Inc.
APVO
TANG CAPITAL PARTNERS LP 1,081
42.500%
0
(Unchanged)
Filing
History
2020-11-16
11:02 am
Purchase
2020-11-05 13G Aptevo Therapeutics Inc.
APVO
RTW Investments, LP 178
8.970%
178increase
(New Position)
Filing
History
2020-11-06
4:52 pm
Purchase
2020-11-03 13D Aptevo Therapeutics Inc.
APVO
TANG CAPITAL PARTNERS LP 1,081
54.400%
1,081increase
(New Position)
Filing
History
Goto Prev, 0, 1